Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.

Lee JJ, Aghdassi E, Cheung AM, Morrison S, Cymet A, Peeva V, Neville C, Hewitt S, DaCosta D, Pineau C, Pope J, Fortin PR.

J Rheumatol. 2012 Jul;39(7):1378-84. doi: 10.3899/jrheum.111589.

PMID:
22660811
2.

High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.

Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program..

Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3.

PMID:
21365460
3.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
4.

Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.

Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.

Arthritis Rheum. 2007 Jun;56(6):1966-73.

5.

Fracture risk in early postmenopausal women assessed using FRAX.

Trémollieres F, Cochet T, Cohade C, Pouillès JM, Ribot C.

Joint Bone Spine. 2010 Jul;77(4):345-8. doi: 10.1016/j.jbspin.2010.04.012.

PMID:
20605507
6.

The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?

Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD.

J Bone Miner Res. 2010 Oct;25(10):2101-7. doi: 10.1002/jbmr.106.

7.

Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals.

Mak A, Lim JQ, Liu Y, Cheak AA, Ho RC.

Rheumatol Int. 2013 Feb;33(2):299-307. doi: 10.1007/s00296-012-2389-1.

PMID:
22441963
8.

Self-reported fractures and associated factors in women with systemic lupus erythematosus.

Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey-Goldman R.

J Rheumatol. 2007 Oct;34(10):2018-23.

PMID:
17787041
9.

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.

Trémollieres FA, Pouillès JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P.

J Bone Miner Res. 2010 May;25(5):1002-9. doi: 10.1002/jbmr.12.

10.

Bone mineral density changes in women with systemic lupus erythematosus.

Boyanov M, Robeva R, Popivanov P.

Clin Rheumatol. 2003 Oct;22(4-5):318-23.

PMID:
14579164
11.

Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation study.

Leslie WD, Lix LM; Manitoba Bone Density Program..

J Bone Miner Res. 2010 Feb;25(2):388-92. doi: 10.1359/jbmr.090804.

12.

Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.

Mok CC, Wong SN, Ma KM.

Rheumatology (Oxford). 2012 Mar;51(3):468-75. doi: 10.1093/rheumatology/ker306.

PMID:
22096013
13.

Bone mineral density in women with systemic lupus erythematosus.

Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E.

Clin Rheumatol. 2002 May;21(2):135-41.

PMID:
12086164
14.

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, Johansson H, Kanis JA.

Osteoporos Int. 2008 Apr;19(4):429-35. doi: 10.1007/s00198-007-0544-4.

15.

Determination of an applicable FRAX model in Korean women.

Lee DY, Lim SJ, Moon YW, Min YK, Choi D, Yoon BK, Park YS.

J Korean Med Sci. 2010 Nov;25(11):1657-60. doi: 10.3346/jkms.2010.25.11.1657.

16.

Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.

Rhew EY, Lee C, Eksarko P, Dyer AR, Tily H, Spies S, Pope RM, Ramsey-Goldman R.

J Rheumatol. 2008 Feb;35(2):230-6.

PMID:
18203323
17.

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

Donaldson MG, Palermo L, Ensrud KE, Hochberg MC, Schousboe JT, Cummings SR.

J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625.

18.

Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program..

J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.

19.

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2.

PMID:
21161509
20.

FRAX provides robust fracture prediction regardless of socioeconomic status.

Brennan SL, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2014 Jan;25(1):61-9. doi: 10.1007/s00198-013-2525-0.

PMID:
24190425

Supplemental Content

Support Center